206 related articles for article (PubMed ID: 16490630)
1. Disposition of ceftazidime after intraperitoneal administration in adolescent patients receiving continuous cycling peritoneal dialysis.
Sisterhen LL; Stowe CD; Farrar HC; Blaszak CK; Blaszak RT
Am J Kidney Dis; 2006 Mar; 47(3):503-8. PubMed ID: 16490630
[TBL] [Abstract][Full Text] [Related]
2. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
Mars RL; Moles K; Pope K; Hargrove P
Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
[TBL] [Abstract][Full Text] [Related]
3. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of peritonitis under continuous ambulatory peritoneal dialysis using intraperitoneal ceftazidime].
Ragnaud JM; Dupon M; Morlat P; Bezian MC; Wone C
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):681-4. PubMed ID: 2677930
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetics of ceftazidime injected peritoneally in continuous ambulatory peritoneal dialysis].
Ryckelynck JP; Vergnaud M; Hurault de Ligny B; Allouche G; Malbruny B; Morel C
Pathol Biol (Paris); 1986 May; 34(5):328-31. PubMed ID: 3534700
[TBL] [Abstract][Full Text] [Related]
6. Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.
Peerapornratana S; Chariyavilaskul P; Kanjanabuch T; Praditpornsilpa K; Eiam-Ong S; Katavetin P
Perit Dial Int; 2017; 37(2):218-224. PubMed ID: 27738089
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal vancomycin and ceftazidime in the treatment of CAPD peritonitis.
Gray HH; Goulding S; Eykyn SJ
Clin Nephrol; 1985 Feb; 23(2):81-4. PubMed ID: 3886227
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intermittent intraperitoneal ceftazidime.
Grabe DW; Bailie GR; Eisele G; Frye RF
Am J Kidney Dis; 1999 Jan; 33(1):111-7. PubMed ID: 9915275
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis in patients with peritonitis.
Montañés Pauls B; Almiñana MA; Casabó Alós VG
Eur J Pharm Sci; 2011 Jul; 43(4):212-6. PubMed ID: 21540106
[TBL] [Abstract][Full Text] [Related]
10. Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis.
Triyawatanyu P; Chariyavilaskul P; Phaisal W; Peerapornratana S; Kanjanabuch T; Praditpornsilpa K; Katavetin P
Perit Dial Int; 2020 Mar; 40(2):179-184. PubMed ID: 32063189
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal cefazolin and ceftazidime effects on human peritoneal mesothelial cell release of cancer antigen-125.
Manley HJ; Elwell RJ; Bailie GR; Welch CL
Ann Pharmacother; 2004 Dec; 38(12):2035-40. PubMed ID: 15536141
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic analysis of ceftazidime and cefazolin in the treatment of continuous ambulatory peritoneal dialysis-related peritonitis.
Zhu W; Fang X; Zheng J; Ke Y; He Q; Cui T; Chen B; Tian L
Ren Fail; 2023; 45(2):2285873. PubMed ID: 38044852
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of clindamycin in the plasma and dialysate after intraperitoneal administration of clindamycin phosphoester to patients on continuous ambulatory peritoneal dialysis: an open-label, prospective, single-dose, two-institution study.
Chang MJ; Namgung H; Choi HD; Song YR; Kim SG; Oh JM; Shin WG
Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):504-9. PubMed ID: 22151828
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study.
Xu R; Yang Z; Qu Z; Wang H; Tian X; Johnson DW; Dong J
Am J Kidney Dis; 2017 Jul; 70(1):30-37. PubMed ID: 28027794
[TBL] [Abstract][Full Text] [Related]
15. Gram-negative peritonitis in children undergoing long-term peritoneal dialysis.
Zurowska A; Feneberg R; Warady BA; Zimmering M; Monteverde M; Testa S; Calyskan S; Drozdz D; Salusky I; Kemper MJ; Ekim M; Verrina E; Misselwitz J; Schaefer F
Am J Kidney Dis; 2008 Mar; 51(3):455-62. PubMed ID: 18295061
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of ceftazidime in CAPD-related peritonitis.
Booranalertpaisarn V; Eiam-Ong S; Wittayalertpanya S; Kanjanabutr T; Na Ayudhya DP
Perit Dial Int; 2003; 23(6):574-9. PubMed ID: 14703199
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacodynamic interest of ceftazidime continuous infusion vs intermittent bolus administration in patients with severe nosocomial pneumonia].
Cousson J; Floch T; Vernet-Garnier V; Appriou M; Petit JS; Jovenin N; Lamiable D; Hoizey G
Pathol Biol (Paris); 2005; 53(8-9):546-50. PubMed ID: 16023303
[TBL] [Abstract][Full Text] [Related]
18. [Monitoring of intraperitoneal administration of vancomycin in patients on continuous ambulatory peritoneal dialysis].
Montañés-Pauls B; Alós Almiñana M; Casabó Alós VG; García Pérez H
Farm Hosp; 2012; 36(5):328-35. PubMed ID: 22264836
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal Vancoled does not cause chemical peritonitis.
Johnson CA; Zimmerman SW; Engeseth S; O'Brien M
Adv Perit Dial; 1989; 5():130-2. PubMed ID: 2577395
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis.
Lye WC; Wong PL; van der Straaten JC; Leong SO; Lee EJ
Adv Perit Dial; 1995; 11():179-81. PubMed ID: 8534699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
